chr5-83538480-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004385.5(VCAN):c.5477G>A(p.Arg1826His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.38 in 1,613,642 control chromosomes in the GnomAD database, including 117,577 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_004385.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VCAN | NM_004385.5 | c.5477G>A | p.Arg1826His | missense_variant | 8/15 | ENST00000265077.8 | NP_004376.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VCAN | ENST00000265077.8 | c.5477G>A | p.Arg1826His | missense_variant | 8/15 | 1 | NM_004385.5 | ENSP00000265077.3 |
Frequencies
GnomAD3 genomes AF: 0.382 AC: 58020AN: 151798Hom.: 11303 Cov.: 32
GnomAD3 exomes AF: 0.384 AC: 96019AN: 250096Hom.: 18761 AF XY: 0.378 AC XY: 51128AN XY: 135400
GnomAD4 exome AF: 0.379 AC: 554355AN: 1461726Hom.: 106270 Cov.: 74 AF XY: 0.376 AC XY: 273669AN XY: 727174
GnomAD4 genome AF: 0.382 AC: 58041AN: 151916Hom.: 11307 Cov.: 32 AF XY: 0.380 AC XY: 28220AN XY: 74258
ClinVar
Submissions by phenotype
Wagner syndrome Benign:3
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 20, 2014 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 14, 2020 | This variant is associated with the following publications: (PMID: 19655167) - |
Vitreoretinopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at